Concepts (280)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aging | 31 | 2023 | 1460 | 3.090 |
Why?
|
| Alzheimer Disease | 33 | 2024 | 2020 | 3.060 |
Why?
|
| Cognitive Dysfunction | 17 | 2024 | 982 | 2.140 |
Why?
|
| Hospitalization | 5 | 2019 | 286 | 1.680 |
Why?
|
| Cognition | 21 | 2024 | 1237 | 1.620 |
Why?
|
| Aged, 80 and over | 55 | 2024 | 4509 | 1.570 |
Why?
|
| Dementia | 11 | 2024 | 519 | 1.550 |
Why?
|
| Health Literacy | 7 | 2018 | 102 | 1.420 |
Why?
|
| Aged | 61 | 2024 | 8382 | 1.290 |
Why?
|
| Independent Living | 12 | 2022 | 280 | 1.280 |
Why?
|
| Female | 63 | 2024 | 14048 | 1.120 |
Why?
|
| Male | 64 | 2024 | 13669 | 1.100 |
Why?
|
| Activities of Daily Living | 10 | 2022 | 571 | 1.010 |
Why?
|
| Humans | 78 | 2024 | 24703 | 0.950 |
Why?
|
| Cohort Studies | 21 | 2024 | 1748 | 0.930 |
Why?
|
| Brain | 16 | 2024 | 1539 | 0.910 |
Why?
|
| Decision Making | 12 | 2016 | 211 | 0.850 |
Why?
|
| Economics | 3 | 2018 | 17 | 0.800 |
Why?
|
| Longitudinal Studies | 18 | 2023 | 1293 | 0.740 |
Why?
|
| DNA-Binding Proteins | 5 | 2022 | 254 | 0.720 |
Why?
|
| Social Behavior | 2 | 2011 | 64 | 0.700 |
Why?
|
| Work | 1 | 2020 | 6 | 0.700 |
Why?
|
| Women | 1 | 2020 | 13 | 0.690 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2021 | 103 | 0.620 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2019 | 17 | 0.610 |
Why?
|
| Emergencies | 1 | 2019 | 29 | 0.600 |
Why?
|
| Cognition Disorders | 6 | 2016 | 943 | 0.570 |
Why?
|
| Neuropsychological Tests | 15 | 2021 | 1135 | 0.550 |
Why?
|
| Social Participation | 2 | 2022 | 12 | 0.540 |
Why?
|
| Interpersonal Relations | 3 | 2014 | 98 | 0.540 |
Why?
|
| Biomarkers | 2 | 2020 | 520 | 0.530 |
Why?
|
| Information Literacy | 2 | 2014 | 9 | 0.530 |
Why?
|
| Risk Assessment | 1 | 2019 | 532 | 0.520 |
Why?
|
| Social Environment | 3 | 2011 | 76 | 0.510 |
Why?
|
| United States | 9 | 2024 | 1873 | 0.510 |
Why?
|
| Motor Activity | 3 | 2013 | 308 | 0.480 |
Why?
|
| Delay Discounting | 1 | 2015 | 24 | 0.460 |
Why?
|
| Risk Reduction Behavior | 1 | 2015 | 39 | 0.460 |
Why?
|
| Trust | 1 | 2014 | 12 | 0.430 |
Why?
|
| Fraud | 1 | 2014 | 21 | 0.430 |
Why?
|
| Caregivers | 10 | 2008 | 185 | 0.420 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2020 | 151 | 0.420 |
Why?
|
| Mental Health | 2 | 2014 | 102 | 0.410 |
Why?
|
| Age Factors | 8 | 2020 | 728 | 0.410 |
Why?
|
| Medicare | 4 | 2024 | 111 | 0.390 |
Why?
|
| Educational Status | 6 | 2020 | 278 | 0.380 |
Why?
|
| Association | 1 | 2011 | 7 | 0.370 |
Why?
|
| Residence Characteristics | 6 | 2016 | 201 | 0.360 |
Why?
|
| Lewy Body Disease | 1 | 2012 | 89 | 0.360 |
Why?
|
| Risk Factors | 11 | 2022 | 2099 | 0.360 |
Why?
|
| Mobility Limitation | 2 | 2012 | 91 | 0.350 |
Why?
|
| Cerebral Infarction | 1 | 2012 | 143 | 0.350 |
Why?
|
| Diet, Mediterranean | 2 | 2023 | 82 | 0.350 |
Why?
|
| Risk | 4 | 2015 | 199 | 0.330 |
Why?
|
| Middle Aged | 20 | 2019 | 8294 | 0.320 |
Why?
|
| Loneliness | 3 | 2023 | 54 | 0.310 |
Why?
|
| Follow-Up Studies | 8 | 2019 | 1671 | 0.300 |
Why?
|
| Memory | 6 | 2018 | 281 | 0.290 |
Why?
|
| Prospective Studies | 6 | 2019 | 1612 | 0.290 |
Why?
|
| Sex Factors | 7 | 2020 | 443 | 0.280 |
Why?
|
| Autopsy | 5 | 2021 | 329 | 0.280 |
Why?
|
| Apolipoprotein E4 | 4 | 2022 | 250 | 0.270 |
Why?
|
| Proportional Hazards Models | 5 | 2016 | 303 | 0.260 |
Why?
|
| Brain Infarction | 2 | 2018 | 75 | 0.260 |
Why?
|
| Quality of Life | 3 | 2012 | 541 | 0.260 |
Why?
|
| Apolipoproteins E | 4 | 2023 | 235 | 0.240 |
Why?
|
| Mental Competency | 4 | 2008 | 8 | 0.240 |
Why?
|
| Social Isolation | 2 | 2023 | 26 | 0.230 |
Why?
|
| Chicago | 7 | 2021 | 858 | 0.230 |
Why?
|
| Mental Status and Dementia Tests | 3 | 2020 | 53 | 0.230 |
Why?
|
| Family | 2 | 2020 | 90 | 0.220 |
Why?
|
| Genotype | 2 | 2018 | 332 | 0.220 |
Why?
|
| Income | 3 | 2022 | 72 | 0.220 |
Why?
|
| Amyloid beta-Peptides | 5 | 2024 | 305 | 0.200 |
Why?
|
| Stress, Psychological | 3 | 2016 | 217 | 0.200 |
Why?
|
| Neuroimaging | 2 | 2021 | 118 | 0.200 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2016 | 286 | 0.190 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2022 | 19 | 0.190 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 193 | 0.180 |
Why?
|
| Disease Progression | 4 | 2020 | 632 | 0.180 |
Why?
|
| Adaptation, Psychological | 1 | 2022 | 163 | 0.180 |
Why?
|
| Depression | 3 | 2015 | 390 | 0.180 |
Why?
|
| Patient Participation | 4 | 2008 | 40 | 0.180 |
Why?
|
| Politics | 3 | 2008 | 10 | 0.180 |
Why?
|
| Cross-Sectional Studies | 8 | 2022 | 807 | 0.170 |
Why?
|
| Financing, Personal | 3 | 2018 | 22 | 0.170 |
Why?
|
| Social Segregation | 1 | 2020 | 7 | 0.170 |
Why?
|
| Employment | 1 | 2020 | 39 | 0.170 |
Why?
|
| Cognitive Reserve | 1 | 2021 | 39 | 0.170 |
Why?
|
| Personality | 1 | 2021 | 51 | 0.170 |
Why?
|
| Brain Diseases | 1 | 2021 | 59 | 0.170 |
Why?
|
| Arteriolosclerosis | 2 | 2021 | 71 | 0.160 |
Why?
|
| Socioeconomic Factors | 2 | 2018 | 279 | 0.160 |
Why?
|
| Awareness | 1 | 2020 | 41 | 0.160 |
Why?
|
| Cognitive Aging | 1 | 2020 | 77 | 0.160 |
Why?
|
| Memory Disorders | 1 | 2020 | 152 | 0.160 |
Why?
|
| Prevalence | 3 | 2012 | 411 | 0.160 |
Why?
|
| Disability Evaluation | 2 | 2011 | 252 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 358 | 0.150 |
Why?
|
| Hospitals, Low-Volume | 1 | 2018 | 5 | 0.150 |
Why?
|
| Hospitals, High-Volume | 1 | 2018 | 6 | 0.150 |
Why?
|
| Mutation | 1 | 2020 | 307 | 0.150 |
Why?
|
| Immunocompromised Host | 1 | 2018 | 39 | 0.150 |
Why?
|
| Research Subjects | 2 | 2008 | 10 | 0.150 |
Why?
|
| Models, Neurological | 1 | 2018 | 24 | 0.150 |
Why?
|
| Blood Glucose | 1 | 2018 | 93 | 0.140 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 113 | 0.140 |
Why?
|
| Neural Pathways | 1 | 2018 | 61 | 0.140 |
Why?
|
| Neurofibrillary Tangles | 4 | 2022 | 182 | 0.140 |
Why?
|
| Regression Analysis | 2 | 2015 | 240 | 0.140 |
Why?
|
| Hospital Mortality | 1 | 2018 | 121 | 0.140 |
Why?
|
| White Matter | 2 | 2016 | 131 | 0.140 |
Why?
|
| Exercise | 1 | 2021 | 399 | 0.140 |
Why?
|
| Learning | 2 | 2016 | 67 | 0.140 |
Why?
|
| Sepsis | 1 | 2018 | 110 | 0.130 |
Why?
|
| Ambulatory Care | 1 | 2017 | 61 | 0.130 |
Why?
|
| Cerebrovascular Disorders | 1 | 2018 | 124 | 0.130 |
Why?
|
| Adult | 6 | 2022 | 7255 | 0.130 |
Why?
|
| Informed Consent | 2 | 2008 | 22 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 150 | 0.130 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2016 | 10 | 0.130 |
Why?
|
| RNA Splicing | 1 | 2016 | 10 | 0.130 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2016 | 15 | 0.130 |
Why?
|
| Incidence | 3 | 2016 | 697 | 0.120 |
Why?
|
| Intelligence | 1 | 2016 | 16 | 0.120 |
Why?
|
| Gray Matter | 1 | 2016 | 50 | 0.120 |
Why?
|
| Interview, Psychological | 2 | 2008 | 40 | 0.120 |
Why?
|
| Comprehension | 1 | 2016 | 29 | 0.120 |
Why?
|
| Chronic Disease | 1 | 2017 | 384 | 0.120 |
Why?
|
| Crime Victims | 1 | 2016 | 26 | 0.120 |
Why?
|
| Alleles | 2 | 2018 | 197 | 0.120 |
Why?
|
| Health Behavior | 2 | 2014 | 154 | 0.120 |
Why?
|
| Time Factors | 3 | 2014 | 1327 | 0.120 |
Why?
|
| Amyloid | 3 | 2021 | 53 | 0.120 |
Why?
|
| Psychological Tests | 1 | 2015 | 49 | 0.120 |
Why?
|
| Racism | 1 | 2015 | 28 | 0.110 |
Why?
|
| Poverty | 1 | 2015 | 88 | 0.110 |
Why?
|
| Multilingualism | 1 | 2014 | 11 | 0.110 |
Why?
|
| Neoplasms | 1 | 2017 | 213 | 0.110 |
Why?
|
| Minority Groups | 1 | 2015 | 67 | 0.110 |
Why?
|
| Music | 1 | 2014 | 21 | 0.110 |
Why?
|
| Social Support | 2 | 2015 | 183 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 138 | 0.110 |
Why?
|
| tau Proteins | 3 | 2022 | 224 | 0.110 |
Why?
|
| Odds Ratio | 4 | 2018 | 251 | 0.100 |
Why?
|
| Parkinsonian Disorders | 1 | 2016 | 205 | 0.100 |
Why?
|
| Neprilysin | 1 | 2012 | 8 | 0.090 |
Why?
|
| Automobile Driving | 1 | 2012 | 20 | 0.090 |
Why?
|
| Actigraphy | 1 | 2012 | 98 | 0.090 |
Why?
|
| Disabled Persons | 1 | 2013 | 107 | 0.090 |
Why?
|
| Lewy Bodies | 3 | 2018 | 177 | 0.090 |
Why?
|
| Muscle Strength | 1 | 2012 | 123 | 0.090 |
Why?
|
| Health Status | 2 | 2012 | 195 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2011 | 39 | 0.090 |
Why?
|
| Environmental Health | 1 | 2010 | 8 | 0.090 |
Why?
|
| Motor Skills Disorders | 1 | 2010 | 15 | 0.090 |
Why?
|
| Severity of Illness Index | 2 | 2005 | 814 | 0.080 |
Why?
|
| Lead Poisoning, Nervous System, Adult | 1 | 2010 | 1 | 0.080 |
Why?
|
| Lead | 1 | 2010 | 2 | 0.080 |
Why?
|
| Phobic Disorders | 1 | 2010 | 65 | 0.080 |
Why?
|
| Occupational Exposure | 1 | 2010 | 17 | 0.080 |
Why?
|
| Urban Population | 1 | 2011 | 141 | 0.080 |
Why?
|
| Occupational Diseases | 1 | 2010 | 22 | 0.080 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 1042 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2011 | 421 | 0.070 |
Why?
|
| Urban Health | 1 | 2008 | 22 | 0.070 |
Why?
|
| Third-Party Consent | 1 | 2008 | 1 | 0.070 |
Why?
|
| Ethics, Research | 1 | 2008 | 3 | 0.070 |
Why?
|
| Assisted Living Facilities | 1 | 2008 | 6 | 0.070 |
Why?
|
| Attitude | 1 | 2008 | 32 | 0.070 |
Why?
|
| Health Services Needs and Demand | 1 | 2008 | 42 | 0.070 |
Why?
|
| Nursing Homes | 1 | 2008 | 41 | 0.070 |
Why?
|
| Delivery of Health Care | 2 | 2015 | 130 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 49 | 0.070 |
Why?
|
| Selegiline | 1 | 2005 | 2 | 0.060 |
Why?
|
| alpha-Tocopherol | 1 | 2005 | 12 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 270 | 0.060 |
Why?
|
| Mood Disorders | 1 | 2005 | 25 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2018 | 555 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2005 | 36 | 0.060 |
Why?
|
| Self Report | 2 | 2016 | 199 | 0.060 |
Why?
|
| Civil Rights | 1 | 2004 | 2 | 0.060 |
Why?
|
| Healthy Lifestyle | 1 | 2024 | 39 | 0.050 |
Why?
|
| Illinois | 2 | 2015 | 221 | 0.050 |
Why?
|
| Statistics as Topic | 2 | 2015 | 103 | 0.050 |
Why?
|
| Vitamins | 1 | 2022 | 16 | 0.050 |
Why?
|
| Vitamin D | 1 | 2022 | 29 | 0.050 |
Why?
|
| Unconsciousness | 1 | 2022 | 7 | 0.050 |
Why?
|
| Infarction | 1 | 2022 | 24 | 0.050 |
Why?
|
| Anthocyanins | 1 | 2022 | 7 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 1026 | 0.050 |
Why?
|
| Fruit | 1 | 2022 | 25 | 0.050 |
Why?
|
| Sclerosis | 1 | 2022 | 66 | 0.050 |
Why?
|
| Logistic Models | 2 | 2018 | 365 | 0.050 |
Why?
|
| Motor Skills | 1 | 2021 | 45 | 0.040 |
Why?
|
| Individuality | 1 | 2021 | 18 | 0.040 |
Why?
|
| Neuroticism | 1 | 2021 | 32 | 0.040 |
Why?
|
| Southeastern United States | 1 | 2020 | 12 | 0.040 |
Why?
|
| Midwestern United States | 1 | 2020 | 48 | 0.040 |
Why?
|
| Baltimore | 2 | 2011 | 10 | 0.040 |
Why?
|
| Religion | 1 | 2019 | 40 | 0.040 |
Why?
|
| Multilevel Analysis | 1 | 2018 | 6 | 0.040 |
Why?
|
| Heterozygote | 1 | 2018 | 95 | 0.040 |
Why?
|
| Neuropathology | 1 | 2018 | 79 | 0.040 |
Why?
|
| Hippocampus | 1 | 2020 | 262 | 0.030 |
Why?
|
| Critical Care | 1 | 2018 | 112 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2017 | 24 | 0.030 |
Why?
|
| Mental Status Schedule | 2 | 2008 | 88 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 294 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 20 | 0.030 |
Why?
|
| Plaque, Amyloid | 1 | 2017 | 141 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2016 | 78 | 0.030 |
Why?
|
| Anisotropy | 1 | 2016 | 42 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 2016 | 86 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2016 | 61 | 0.030 |
Why?
|
| Diagnosis | 1 | 2015 | 23 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 210 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 85 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2015 | 18 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 156 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 68 | 0.030 |
Why?
|
| Cities | 1 | 2015 | 15 | 0.030 |
Why?
|
| Memory, Episodic | 1 | 2016 | 110 | 0.030 |
Why?
|
| Financial Management | 1 | 2015 | 23 | 0.030 |
Why?
|
| Life Change Events | 1 | 2014 | 37 | 0.030 |
Why?
|
| Empathy | 1 | 2014 | 33 | 0.030 |
Why?
|
| Mental Recall | 1 | 2014 | 60 | 0.030 |
Why?
|
| Language | 1 | 2014 | 53 | 0.030 |
Why?
|
| Spouses | 2 | 2005 | 31 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 560 | 0.030 |
Why?
|
| Spatial Behavior | 1 | 2012 | 8 | 0.020 |
Why?
|
| Licensure | 1 | 2012 | 8 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 2012 | 21 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 20 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 14 | 0.020 |
Why?
|
| Environment | 1 | 2012 | 38 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 21 | 0.020 |
Why?
|
| Mice | 1 | 2016 | 1296 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 49 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 115 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 243 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 234 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 294 | 0.020 |
Why?
|
| Reaction Time | 1 | 2011 | 89 | 0.020 |
Why?
|
| Data Collection | 1 | 2011 | 86 | 0.020 |
Why?
|
| Executive Function | 1 | 2011 | 102 | 0.020 |
Why?
|
| Psychometrics | 1 | 2011 | 197 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2010 | 40 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 93 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 178 | 0.020 |
Why?
|
| Survival Rate | 1 | 2010 | 285 | 0.020 |
Why?
|
| Animals | 1 | 2016 | 3330 | 0.020 |
Why?
|
| Intermittent Claudication | 1 | 2008 | 3 | 0.020 |
Why?
|
| Family Characteristics | 1 | 2008 | 20 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 2008 | 17 | 0.020 |
Why?
|
| Prognosis | 1 | 2010 | 674 | 0.020 |
Why?
|
| Social Class | 1 | 2008 | 59 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2008 | 99 | 0.020 |
Why?
|
| Observer Variation | 1 | 2008 | 95 | 0.020 |
Why?
|
| Health Surveys | 1 | 2008 | 84 | 0.020 |
Why?
|
| Simvastatin | 1 | 2008 | 14 | 0.020 |
Why?
|
| ROC Curve | 1 | 2008 | 131 | 0.020 |
Why?
|
| Tibia | 1 | 2010 | 244 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2008 | 102 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 3208 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 250 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 437 | 0.020 |
Why?
|
| Professional-Family Relations | 1 | 2005 | 17 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2005 | 46 | 0.010 |
Why?
|
| Judgment | 1 | 2005 | 6 | 0.010 |
Why?
|
| Nootropic Agents | 1 | 2005 | 14 | 0.010 |
Why?
|
| Stroke | 1 | 2008 | 254 | 0.010 |
Why?
|
| Policy Making | 1 | 2004 | 11 | 0.010 |
Why?
|
| Long-Term Care | 1 | 2004 | 54 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2005 | 144 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2003 | 125 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2003 | 123 | 0.010 |
Why?
|
| Pennsylvania | 1 | 2002 | 5 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2002 | 87 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 598 | 0.010 |
Why?
|